Sign In

Sonia Guedan

Principal Investigator, Ramon y Cajal Fellow at Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Sonia Guedan is a prominent researcher in the field of cancer immunotherapy, currently serving as a Principal Investigator and Ramon y Cajal Fellow at the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in Barcelona, Spain.1

Research Focus

Dr. Guedan's primary research focus is on developing new CAR-T cell therapies for the treatment of solid tumors.1 Her laboratory aims to:

  1. Understand the obstacles that lead to CAR therapy failure in solid tumors
  2. Develop strategies to overcome these hurdles
  3. Move CAR-T cells for solid tumors into clinical applications

Career Highlights

  • Current Position: Principal Investigator and Ramon y Cajal Fellow at IDIBAPS (since May 2020)1
  • Previous Roles:
    • Junior Investigator at IDIBAPS (2018-2020)
    • Research Lead at the June Laboratory, University of Pennsylvania School of Medicine (2015-2018)
    • Marie Curie Post-doctoral Fellow at Bellvitge Biomedical Research Institute - IDIBELL (2014-2015)
    • Postdoctoral researcher at the University of Pennsylvania (2010-2014)

Education and Expertise

Dr. Guedan holds a degree in Pharmacy from the University of Barcelona.1 She has over 15 years of experience in developing gene and cell-based therapies for cancer treatment.1 Her expertise includes:

  • CAR-T cell therapy
  • Solid tumor immunotherapy
  • T cell exhaustion
  • Tumor escape mechanisms

Achievements and Recognition

  • Recipient of the prestigious Ramon y Cajal Fellowship3
  • Board member of the Spanish Society for Gene and Cell Therapy (SETGyC)3
  • Has received funding from the Spanish Ministry of Science and Innovation2

Dr. Guedan's work aims to advance the field of cancer immunotherapy, with a particular focus on overcoming the challenges of treating solid tumors with CAR-T cell therapy.

Highlights

Sep 16 · cicancer.org
[PDF] CVN - Sonia Guedan Carrio - Cancer Research Center

Related Questions

What are the main challenges in developing CAR-T cell therapies for solid tumors?
How does Sonia Guedan's work at IDIBAPS differ from her previous roles?
What strategies is Sonia Guedan using to overcome CAR therapy failure in solid tumors?
Can you provide more details about the Ramon y Cajal Fellowship and its significance?
What are some recent breakthroughs in CAR-T cell therapies for solid tumors?
Sonia Guedan
Sonia Guedan, photo 1
Sonia Guedan, photo 2
Add to my network

Location

Philadelphia, Pennsylvania, United States